[Sleep-disordered breathing in children]

Arch Pediatr. 2009 Feb;16(2):123-31. doi: 10.1016/j.arcped.2008.11.016. Epub 2008 Dec 20.
[Article in French]

Abstract

Sleep-disordered breathing (SDB) in children comprises a wide spectrum of symptoms ranging from primary snoring to obstructive sleep apnea (OSA). Twelve percent of children present primary snoring and 1-2% OSA. Polysomnography is the gold standard for diagnosis of SDB allowing the analysis of sleep stages, respiratory movements, airflow, and gas exchange. However, this test remains highly technical, expensive, and difficult to conduct; other simpler diagnostic methods are under evaluation. Recent studies highlight the frequency and importance of cognitive and behavioral disorders in children with SDB; both the age and the severity of the SDB seem to modulate in the expression of neurocognitive consequences. Local and systemic inflammation plays a key role in the physiopathology of SDB and its complications: OSA is a cardiovascular risk factor in childhood that could favor atheromatous complications later in life. Adenoidotonsillectomy is the treatment of choice, but anti-inflammatory therapies such as leukotriene receptor antagonists or nasal corticoids may be beneficial in mild SDB or in residual OSA after adenotonsillectomy. In case of failure, noninvasive ventilation by means of nasal continuous positive pressure will be necessary, aided by specialists. SDB and OSA are a public health problem, underlining the pivotal role of the pediatrician in preventing, diagnosing, and treating these frequent disorders.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adenoidectomy
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Child
  • Cognition Disorders / physiopathology
  • Humans
  • Inflammation / drug therapy
  • Inflammation / physiopathology
  • Polysomnography
  • Positive-Pressure Respiration
  • Risk Factors
  • Sleep Apnea Syndromes / diagnosis*
  • Sleep Apnea Syndromes / physiopathology
  • Sleep Apnea Syndromes / therapy
  • Tonsillectomy

Substances

  • Anti-Inflammatory Agents, Non-Steroidal